Fontan Udenafil Exercise Longitudinal Assessment Trial (FUEL)
Phase of Trial: Phase III
Latest Information Update: 31 Aug 2017
At a glance
- Drugs Udenafil (Primary)
- Indications Congenital heart defects; Ventricular dysfunction
- Focus Registrational; Therapeutic Use
- Acronyms FUEL
- Sponsors Mezzion
- 24 Aug 2017 Planned End Date changed from 1 Dec 2017 to 1 Jul 2018.
- 24 Aug 2017 Planned primary completion date changed from 1 Sep 2017 to 1 Jul 2018.
- 25 Jul 2016 Status changed from not yet recruiting to recruiting.